Hydroxychloroquine Market, By Disease Type (Coronavirus Disease (COVID-19), Malaria, Q Fever, Rheumatoid Arthritis, Lupus Erythematosus, Porphyria Cutanea Tarda (PCT), and Other Disease Types), By Distribution Channel (Specialty Drug Store, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029

The hydroxychloroquine market is divided into four regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. By 2026, significant growth is anticipated in North America, comprised of the United States, Canada, and Mexico. Increased product consumption in the area due to increased coronavirus cases and numerous clinical trials will drive the hydroxychloroquine market. India, a significant producer and supplier of hydroxychloroquine, has sent over 3.5 million tablets and 8.5 metric tons of components to the United States for coronavirus therapy.